Market Closed -
Nasdaq
21:00:00 02/05/2024 BST
|
5-day change
|
1st Jan Change
|
6.53
USD
|
+1.24%
|
|
+6.01%
|
-16.60%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
3,562
|
1,857
|
2,964
|
2,465
|
-
|
-
|
Enterprise Value (EV)
1 |
3,585
|
1,974
|
3,166
|
2,651
|
2,583
|
2,474
|
P/E ratio
|
-9.07
x
|
-8.1
x
|
-15.4
x
|
-23
x
|
-30.2
x
|
-48.8
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
5.34
x
|
2.16
x
|
2.81
x
|
2.02
x
|
1.78
x
|
1.57
x
|
EV / Revenue
|
5.37
x
|
2.3
x
|
3
x
|
2.18
x
|
1.87
x
|
1.58
x
|
EV / EBITDA
|
72.9
x
|
37.5
x
|
53.6
x
|
31.4
x
|
21.4
x
|
16
x
|
EV / FCF
|
-42.1
x
|
-74.6
x
|
-55.2
x
|
251
x
|
66.2
x
|
43.4
x
|
FCF Yield
|
-2.37%
|
-1.34%
|
-1.81%
|
0.4%
|
1.51%
|
2.3%
|
Price to Book
|
2.31
x
|
1.22
x
|
2.08
x
|
1.79
x
|
1.81
x
|
1.82
x
|
Nbr of stocks (in thousands)
|
374,149
|
375,986
|
378,607
|
382,239
|
-
|
-
|
Reference price
2 |
9.520
|
4.940
|
7.830
|
6.530
|
6.530
|
6.530
|
Announcement Date
|
10/03/22
|
08/03/23
|
28/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
377.2
|
667.5
|
859.5
|
1,056
|
1,219
|
1,382
|
1,566
|
EBITDA
1 |
-
|
49.15
|
52.67
|
59.04
|
84.4
|
120.8
|
154.8
|
EBIT
1 |
-
|
-286.4
|
-210.2
|
-189.1
|
-93.87
|
-66.62
|
-36.68
|
Operating Margin
|
-
|
-42.9%
|
-24.45%
|
-17.92%
|
-7.7%
|
-4.82%
|
-2.34%
|
Earnings before Tax (EBT)
1 |
-
|
-333.1
|
-232.7
|
-206.6
|
-111.6
|
-85.34
|
-60.83
|
Net income
1 |
-311.3
|
-343.9
|
-215.6
|
-186.3
|
-103.6
|
-76.08
|
-47.85
|
Net margin
|
-82.53%
|
-51.53%
|
-25.08%
|
-17.64%
|
-8.5%
|
-5.5%
|
-3.06%
|
EPS
2 |
-
|
-1.050
|
-0.6100
|
-0.5100
|
-0.2845
|
-0.2165
|
-0.1338
|
Free Cash Flow
1 |
-
|
-85.07
|
-26.47
|
-57.4
|
10.57
|
39
|
57
|
FCF margin
|
-
|
-12.74%
|
-3.08%
|
-5.44%
|
0.87%
|
2.82%
|
3.64%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
12.53%
|
32.27%
|
36.83%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
12/04/21
|
10/03/22
|
08/03/23
|
28/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
173.8
|
190.1
|
203.1
|
209.5
|
217.6
|
229.4
|
252.6
|
259.6
|
262.9
|
280.6
|
299
|
305.7
|
303.5
|
315
|
333
|
EBITDA
1 |
10.69
|
11.4
|
12.48
|
14.63
|
15.38
|
10.18
|
10.1
|
14.06
|
14.58
|
20.29
|
20.64
|
20.36
|
20.66
|
23.95
|
27.16
|
EBIT
1 |
-124.7
|
-113.8
|
-64.85
|
-60.47
|
-38.84
|
-46.01
|
-34.09
|
-48.41
|
-74.36
|
-32.27
|
-25.4
|
-27.4
|
-26.4
|
-23.9
|
-
|
Operating Margin
|
-71.72%
|
-59.84%
|
-31.93%
|
-28.86%
|
-17.85%
|
-20.06%
|
-13.5%
|
-18.65%
|
-28.28%
|
-11.5%
|
-8.5%
|
-8.96%
|
-8.7%
|
-7.59%
|
-
|
Earnings before Tax (EBT)
1 |
-129.2
|
-118.6
|
-69
|
-67.8
|
-42.21
|
-53.72
|
-38.28
|
-52.02
|
-77.97
|
-38.32
|
-33
|
-30
|
-30
|
-28
|
-
|
Net income
1 |
-120.5
|
-144.8
|
-62.33
|
-68.73
|
-37.85
|
-46.66
|
-34.24
|
-45.48
|
-61.58
|
-44.96
|
-30.75
|
-29.15
|
-28.2
|
-25.85
|
-
|
Net margin
|
-69.29%
|
-76.16%
|
-30.69%
|
-32.8%
|
-17.4%
|
-20.34%
|
-13.56%
|
-17.52%
|
-23.42%
|
-16.02%
|
-10.29%
|
-9.54%
|
-9.29%
|
-8.21%
|
-
|
EPS
2 |
-0.3500
|
-0.3200
|
-0.1800
|
-0.1900
|
-0.1100
|
-0.1300
|
-0.0900
|
-0.1300
|
-0.1700
|
-0.1200
|
-0.0879
|
-0.0714
|
-0.0700
|
-0.0672
|
-0.0585
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
08/11/21
|
10/03/22
|
09/05/22
|
09/08/22
|
08/11/22
|
08/03/23
|
10/05/23
|
09/08/23
|
08/11/23
|
28/02/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
23.5
|
116
|
201
|
186
|
117
|
8.96
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
0.4783
x
|
2.211
x
|
3.412
x
|
2.201
x
|
0.9708
x
|
0.0579
x
|
Free Cash Flow
1 |
-
|
-85.1
|
-26.5
|
-57.4
|
10.6
|
39
|
57
|
ROE (net income / shareholders' equity)
|
-
|
-27.1%
|
-14.1%
|
-12.6%
|
-7.3%
|
-5.03%
|
-3.32%
|
ROA (Net income/ Total Assets)
|
-
|
-19.7%
|
-10.5%
|
-8.7%
|
-5.07%
|
-3.9%
|
-3.18%
|
Assets
1 |
-
|
1,748
|
2,050
|
2,142
|
2,043
|
1,953
|
1,505
|
Book Value Per Share
2 |
-
|
4.130
|
4.040
|
3.770
|
3.650
|
3.610
|
3.600
|
Cash Flow per Share
2 |
-
|
0.0300
|
0.1500
|
-0.0500
|
0.1100
|
0.2400
|
-
|
Capex
1 |
-
|
94.5
|
79.3
|
40.5
|
39.4
|
57.7
|
69.3
|
Capex / Sales
|
-
|
14.16%
|
9.22%
|
3.84%
|
3.23%
|
4.17%
|
4.43%
|
Announcement Date
|
12/04/21
|
10/03/22
|
08/03/23
|
28/02/24
|
-
|
-
|
-
|
Last Close Price
6.53
USD Average target price
8.786
USD Spread / Average Target +34.54% Consensus |
1st Jan change
|
Capi.
|
---|
| -16.60% | 2.47B | | +14.10% | 81.84B | | -30.15% | 70.69B | | +9.37% | 29.03B | | -11.90% | 16.97B | | -0.36% | 16.83B | | -1.12% | 15.28B | | +5.90% | 12.41B | | +35.78% | 12.26B | | -4.20% | 11.86B |
Other Healthcare Facilities & Services
|